BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 32336255)

  • 1. Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases.
    Pontoriero A; Iatì G; Cacciola A; Conti A; Brogna A; Siragusa C; Ferini G; Davì V; Tamburella C; Molino L; Cambareri D; Severo C; Parisi S; Settineri N; Ielo I; Pergolizzi S
    Technol Cancer Res Treat; 2020; 19():1533033820904447. PubMed ID: 32336255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.
    Lubgan D; Ziegaus A; Semrau S; Lambrecht U; Lettmaier S; Fietkau R
    Strahlenther Onkol; 2015 Mar; 191(3):264-71. PubMed ID: 25395089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
    Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
    Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT based quantitative measures of the stability of fractured metastatically involved vertebrae treated with spine stereotactic body radiotherapy.
    Hardisty M; Wright T; Campbell M; Burke M; Atenafu E; Cawricz M; Caldwell C; Yee A; Sahgal A; Whyne C
    Clin Exp Metastasis; 2020 Oct; 37(5):575-584. PubMed ID: 32643007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study.
    Deodato F; Pezzulla D; Cilla S; Ferro M; Giannini R; Romano C; Boccardi M; Buwenge M; Valentini V; Morganti AG; Macchia G
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e30-e39. PubMed ID: 36207236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
    Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery.
    Katsoulakis E; Laufer I; Bilsky M; Agaram NP; Lovelock M; Yamada Y
    Neurosurg Focus; 2017 Jan; 42(1):E7. PubMed ID: 28041326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
    Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
    Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL
    J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spine stereotactic radiosurgery for the treatment of multiple myeloma.
    Miller JA; Balagamwala EH; Chao ST; Emch T; Suh JH; Djemil T; Angelov L
    J Neurosurg Spine; 2017 Mar; 26(3):282-290. PubMed ID: 27791828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.
    Wardak Z; Bland R; Ahn C; Xie XJ; Chason D; Morrill K; Stehel E; Nedzi L; Ding C; Medin P; Boike T; Abdulrahman R; Folkert M; Iyengar P; Kim N; Choy H; Bagley C; Timmerman R
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):83-89. PubMed ID: 30684664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution.
    Ito K; Ogawa H; Shimizuguchi T; Nihei K; Furuya T; Tanaka H; Karasawa K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806472. PubMed ID: 30355246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials.
    Bernstein MB; Chang EL; Amini B; Pan H; Cabanillas M; Wang XA; Allen PK; Rhines LD; Tatsui C; Li J; Brown PD; Ghia AJ
    Thyroid; 2016 Sep; 26(9):1269-75. PubMed ID: 27334245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-Year Outcomes of High-Dose Single-Fraction Spinal Stereotactic Radiosurgery.
    Moussazadeh N; Lis E; Katsoulakis E; Kahn S; Svoboda M; DiStefano NM; McLaughlin L; Bilsky MH; Yamada Y; Laufer I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):361-7. PubMed ID: 26232858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.